A comparative review of toll-like receptor 4 expression and functionality in different animal species

Frontiers in Immunology

Volumn 5, Issue JUL, 2014, Pages

  Vaure, Céline ^a   Liu, Yuanqing ^a  

^a SANOFI PASTEUR   (France)

Author keywords

Dog; Human; Mouse; Non human primate; Rabbit; Rat; Swine; Toll like receptor 4

Indexed keywords

EID: 84905657637     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00316     Document Type: Review

References (114)

1. Janssens S, Beyaert R. Role of toll-like receptors in pathogen recognition. Clin Microbiol Rev (2003) 16:637-46. doi: 10.1128/CMR.16.4.637-646.2003
2. Kanzler H, Barrat FJ, Hessel EM, Coffman RL. Therapeutic targeting of innate immunity with toll-like receptor agonists and antagonists. Nat Med (2007) 13:552-9. doi:10.1038/nm1589
3. Alving CR, Peachman KK, Rao M, Reed SG. Adjuvants for human vaccines. Curr Opin Immunol (2012) 24:310-5. doi:10.1016/j.coi.2012.03.008
4. Ireton GC, Reed SG. Adjuvants containing natural and synthetic toll-like receptor 4 ligands. Expert Rev Vaccines (2013) 12:793-807. doi:10.1586/14760584.2013.811204
5. Johnson DA. TLR4 agonists as vaccine adjuvants: a chemist's perspective. Expert Rev Vaccines (2013) 12:711-3. doi:10.1586/14760584.2013.811189
6. Meyer J, McShane H. The next 10 years for tuberculosis vaccines: do we have the right plans in place? Expert Rev Vaccines (2013) 12:443-51. doi:10.1586/erv.13.19
7. Treanor JJ, Essink B, Hull S, Reed S, Izikson R, Patriarca P, et al. Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5/Indonesia/05/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE+GLA) adjuvant. Vaccine (2013) 31:5760-5. doi:10.1016/j.vaccine.2013.08.064
8. Schroder K, Irvine KM, Taylor MS, Bokil NJ, Le Cao KA, Masterman KA, et al. Conservation and divergence in toll-like receptor 4-regulated gene expression in primary human versus mouse macrophages. Proc Natl Acad Sci U S A (2012) 109:E944-53. doi:10.1073/pnas.1110156109
9. Ketloy C, Engering A, Srichairatanakul U, Limsalakpetch A, Yongvanitchit K, Pichyangkul S, et al. Expression and function of toll-like receptors on dendritic cells and other antigen presenting cells from non-human primates. Vet Immunol Immunopathol (2008) 125:18-30. doi:10.1016/j.vetimm.2008.05.001
10. Rehli M. Of mice and men: species variations of toll-like receptor expression. Trends Immunol (2002) 23:375-8. doi:10.1016/S1471-4906(02)02259-7
11. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila toll protein signals activation of adaptive immunity. Nature (1997) 388:394-7. doi:10.1038/41131
12. Medzhitov R, Janeway CA Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell (1997) 91:295-8. doi:10.1016/S0092-8674(00)80412-2
13. Werling D, Jungi TW. Toll-like receptors linking innate and adaptive immune response. Vet Immunol Immunopathol (2003) 91:1-12. doi:10.1016/S0165-2427(02)00228-3
14. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol (2004) 4:499-511. doi:10.1038/nri1391
15. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol (2010) 11:373-84. doi:10.1038/ni.1863
16. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science (1998) 282:2085-8. doi:10.1126/science.282.5396.2085
17. Qureshi ST, Lariviere L, Leveque G, Clermont S, Moore KJ, Gros P, et al. Endotoxin-tolerant mice have mutations in toll-like receptor 4 (Tlr4). J Exp Med (1999) 189:615-25. doi:10.1084/jem.189.4.615
18. Flo TH, Ryan L, Latz E, Takeuchi O, Monks BG, Lien E, et al. Involvement of toll-like receptor (TLR) 2 and TLR4 in cell activation by mannuronic acid polymers. J Biol Chem (2002) 277:35489-95. doi:10.1074/jbc.M201366200
19. Yang S, Sugawara S, Monodane T, Nishijima M, Adachi Y, Akashi S, et al. Micrococcus luteus teichuronic acids activate human and murine monocytic cells in a CD14- and toll-like receptor 4-dependent manner. Infect Immun (2001) 69:2025-30. doi:10.1128/IAI.69.4.2025-2030.2001
20. Haynes LM, Moore DD, Kurt-Jones EA, Finberg RW, Anderson LJ, Tripp RA. Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J Virol (2001) 75:10730-7. doi:10.1128/JVI.75.22.10730-10737.2001
21. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol (2000) 1:398-401. doi:10.1038/80833
22. Ohashi K, Burkart V, Flohe S, Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol (2000) 164:558-61. doi:10.4049/jimmunol.164.2.558
23. Vabulas RM, Ahmad-Nejad P, da Costa C, Miethke T, Kirschning CJ, Hacker H, et al. Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem (2001) 276:31332-9. doi:10.1074/jbc.M103217200
24. Kim SC, Stice JP, Chen L, Jung JS, Gupta S, Wang Y, et al. Extracellular heat shock protein 60, cardiac myocytes, and apoptosis. Circ Res (2009) 105:1186-95. doi:10.1161/CIRCRESAHA.109.209643
25. Roelofs MF, Boelens WC, Joosten LA, Abdollahi-Roodsaz S, Geurts J, Wunderink LU, et al. Identification of small heat shock protein B8 (HSP22) as a novel TLR4 ligand and potential involvement in the pathogenesis of rheumatoid arthritis. J Immunol (2006) 176:7021-7. doi:10.4049/jimmunol.176.11.7021
26. Gondokaryono SP, Ushio H, Niyonsaba F, Hara M, Takenaka H, Jayawardana ST, et al. The extra domain A of fibronectin stimulates murine mast cells via toll-like receptor 4. J Leukoc Biol (2007) 82:657-65. doi:10.1189/jlb.1206730
27. Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J, et al. The extra domain A of fibronectin activates toll-like receptor 4. J Biol Chem (2001) 276:10229-33. doi:10.1074/jbc.M100099200
28. Kim F, Pham M, Luttrell I, Bannerman DD, Tupper J, Thaler J, et al. Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ Res (2007) 100:1589-96. doi:10.1161/CIRCRESAHA.106.142851
29. Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, Prada PO, Hirabara SM, Schenka AA, et al. Loss-of-function mutation in toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes (2007) 56:1986-98. doi:10.2337/db06-1595
30. Figueiredo RT, Fernandez PL, Mourao-Sa DS, Porto BN, Dutra FF, Alves LS, et al. Characterization of heme as activator of toll-like receptor 4. J Biol Chem (2007) 282:20221-9. doi:10.1074/jbc.M610737200
31. Choi SH, Harkewicz R, Lee JH, Boullier A, Almazan F, Li AC, et al. Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake. Circ Res (2009) 104:1355-63. doi:10.1161/CIRCRESAHA.108.192880
32. Fitzgerald KA, Rowe DC, Golenbock DT. Endotoxin recognition and signal transduction by the TLR4/MD2-complex. Microbes Infect (2004) 6:1361-7. doi:10.1016/j.micinf.2004.08.015
33. Miller SI, Ernst RK, Bader MW. LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol (2005) 3:36-46. doi:10.1038/nrmicro1068
34. Park BS, Song DH, Kim HM, Choi BS, Lee H, Lee JO. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature (2009) 458:1191-5. doi:10.1038/nature07830
35. Lizundia R, Sauter KS, Taylor G, Werling D. Host species-specific usage of the TLR4-LPS receptor complex. Innate Immun (2008) 14:223-31. doi:10.1177/1753425908095957
36. Vasl J, Oblak A, Gioannini TL, Weiss JP, Jerala R. Novel roles of lysines 122, 125, and 58 in functional differences between human and murine MD-2. J Immunol (2009) 183:5138-45. doi:10.4049/jimmunol.0901544
37. Doyle SL, O'Neill LA. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem Pharmacol (2006) 72:1102-13. doi:10.1016/j.bcp.2006.07.010
38. O'Neill LA, Fitzgerald KA, Bowie AG. The toll-IL-1 receptor adaptor family grows to five members. Trends Immunol (2003) 24:286-90. doi:10.1016/S1471-4906(03)00115-7
39. Jungi TW, Farhat K, Burgener IA, Werling D. Toll-like receptors in domestic animals. Cell Tissue Res (2011) 343:107-20. doi:10.1007/s00441-010-1047-8
40. Mink M, Fogelgren B, Olszewski K, Maroy P, Csiszar K. A novel human gene (SARM) at chromosome 17q11 encodes a protein with a SAM motif and structural similarity to Armadillo/beta-catenin that is conserved in mouse, Drosophila, and Caenorhabditis elegans. Genomics (2001) 74:234-44. doi:10.1006/geno.2001.6548
41. Carty M, Goodbody R, Schroder M, Stack J, Moynagh PN, Bowie AG. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent toll-like receptor signaling. Nat Immunol (2006) 7:1074-81. doi:10.1038/ni1382
42. Thomas AV, Broers AD, Vandegaart HF, Desmecht DJ. Genomic structure, promoter analysis and expression of the porcine (Sus scrofa) TLR4 gene. Mol Immunol (2006) 43:653-9. doi:10.1016/j.molimm.2005.04.001
43. Werling D, Jann OC, Offord V, Glass EJ, Coffey TJ. Variation matters: TLR structure and species-specific pathogen recognition. Trends Immunol (2009) 30:124-30. doi:10.1016/j.it.2008.12.001
44. Hajjar AM, Ernst RK, Tsai JH, Wilson CB, Miller SI. Human toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol (2002) 3:354-9. doi:10.1038/ni777
45. Jann OC, King A, Corrales NL, Anderson SI, Jensen K, Ait-Ali T, et al. Comparative genomics of toll-like receptor signalling in five species. BMC Genomics (2009) 10:216. doi:10.1186/1471-2164-10-216
46. Smirnova I, Poltorak A, Chan EK, McBride C, Beutler B. Phylogenetic variation and polymorphism at the toll-like receptor 4 locus (TLR4). Genome Biol (2000) 1:RESEARCH002. doi:10.1186/gb-2000-1-1-research002
47. Kajikawa O, Frevert CW, Lin SM, Goodman RB, Mongovin SM, Wong V, et al. Gene expression of toll-like receptor-2, toll-like receptor-4, and MD2 is differentially regulated in rabbits with Escherichia coli pneumonia. Gene (2005) 344:193-202. doi:10.1016/j.gene.2004.09.032
48. Uenishi H, Shinkai H. Porcine toll-like receptors: the front line of pathogen monitoring and possible implications for disease resistance. Dev Comp Immunol (2009) 33:353-61. doi:10.1016/j.dci.2008.06.001
49. Sanghavi SK, Shankarappa R, Reinhart TA. Genetic analysis of toll/Interleukin-1 Receptor (TIR) domain sequences from rhesus macaque toll-like receptors (TLRs) 1-10 reveals high homology to human TLR/TIR sequences. Immunogenetics (2004) 56:667-74. doi:10.1007/s00251-004-0734-6
50. Wells CA, Ravasi T, Faulkner GJ, Carninci P, Okazaki Y, Hayashizaki Y, et al. Genetic control of the innate immune response. BMC Immunol (2003) 4:5. doi:10.1186/1471-2172-4-5
51. Turin L, Riva F. Toll-like receptor family in domestic animal species. Crit Rev Immunol (2008) 28:513-38. doi:10.1615/CritRevImmunol.v28.i6.30
52. Alvarez B, Revilla C, Chamorro S, Lopez-Fraga M, Alonso F, Dominguez J, et al. Molecular cloning, characterization and tissue expression of porcine toll-like receptor 4. Dev Comp Immunol (2006) 30:345-55. doi:10.1016/j.dci.2005.06.020
53. Asahina Y, Yoshioka N, Kano R, Moritomo T, Hasegawa A. Full-length cDNA cloning of toll-like receptor 4 in dogs and cats. Vet Immunol Immunopathol (2003) 96:159-67. doi:10.1016/S0165-2427(03)00159-4
54. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T, et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol (2002) 168:4531-7. doi:10.4049/jimmunol.168.9.4531
55. Muzio M, Bosisio D, Polentarutti N, D'amico G, Stoppacciaro A, Mancinelli R, et al. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol (2000) 164:5998-6004. doi:10.4049/jimmunol.164.11.5998
56. Zarember KA, Godowski PJ. Tissue expression of human toll-like receptors and differential regulation of toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol (2002) 168:554-61. doi:10.4049/jimmunol.168.2.554
57. Peng SL. Signaling in B cells via toll-like receptors. Curr Opin Immunol (2005) 17:230-6. doi:10.1016/j.coi.2005.03.003
58. Mita Y, Dobashi K, Endou K, Kawata T, Shimizu Y, Nakazawa T, et al. Toll-like receptor 4 surface expression on human monocytes and B cells is modulated by IL-2 and IL-4. Immunol Lett (2002) 81:71-5. doi:10.1016/S0165-2478(01)00328-5
59. Visintin A, Mazzoni A, Spitzer JH, Wyllie DH, Dower SK, Segal DM. Regulation of toll-like receptors in human monocytes and dendritic cells. J Immunol (2001) 166:249-55. doi:10.4049/jimmunol.166.1.249
60. Re F, Strominger JL. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem (2001) 276:37692-9. doi:10.1074/jbc.M105927200
61. Dasu MR, Devaraj S, Zhao L, Hwang DH, Jialal I. High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes (2008) 57:3090-8. doi:10.2337/db08-0564
62. Garay-Malpartida HM, Mourao RF, Mantovani M, Santos IA, Sogayar MC, Goldberg AC. Toll-like receptor 4 (TLR4) expression in human and murine pancreatic beta-cells affects cell viability and insulin homeostasis. BMC Immunol (2011) 12:18. doi:10.1186/1471-2172-12-18
63. Bes-Houtmann S, Roche R, Hoareau L, Gonthier MP, Festy F, Caillens H, et al. Presence of functional TLR2 and TLR4 on human adipocytes. Histochem Cell Biol (2007) 127:131-7. doi:10.1007/s00418-006-0230-1
64. Ren M, Gao L, Wu X. TLR4: the receptor bridging Acanthamoeba challenge and intracellular inflammatory responses in human corneal cell lines. Immunol Cell Biol (2010) 88:529-36. doi:10.1038/icb.2010.6
65. Bsibsi M, Ravid R, Gveric D, van Noort JM. Broad expression of toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol (2002) 61:1013-21.
66. Nagyoszi P, Wilhelm I, Farkas AE, Fazakas C, Dung NT, Hasko J, et al. Expression and regulation of toll-like receptors in cerebral endothelial cells. Neurochem Int (2010) 57:556-64. doi:10.1016/j.neuint.2010.07.002
67. Eissler R, Schmaderer C, Rusai K, Kuhne L, Sollinger D, Lahmer T, et al. Hypertension augments cardiac toll-like receptor 4 expression and activity. Hypertens Res (2011) 34:551-8. doi:10.1038/hr.2010.270
68. Faure E, Equils O, Sieling PA, Thomas L, Zhang FX, Kirschning CJ, et al. Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J Biol Chem (2000) 275:11058-63. doi:10.1074/jbc.275.15.11058
69. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun (2000) 68:7010-7. doi:10.1128/IAI.68.12.7010-7017.2000
70. Imaeda H, Yamamoto H, Takaki A, Fujimiya M. In vivo response of neutrophils and epithelial cells to lipopolysaccharide injected into the monkey ileum. Histochem Cell Biol (2002) 118:381-8. doi:10.1007/s00418-002-0458-3
71. Asquith M, Haberthur K, Brown M, Engelmann F, Murphy A, Al Mahdi Z, et al. Age-dependent changes in innate immune phenotype and function in rhesus macaques (Macaca mulatta). Pathobiol Aging Age Relat Dis (2012) 2:18052. doi:10.3402/pba.v2i0.18052
72. O'Neill LA. DisSARMing toll-like receptor signaling. Nat Immunol (2006) 7:1023-5. doi:10.1038/ni1006-1023
73. Wu H, Liu L, Tan Q, Wang C, Guo M, Xie Y, et al. Somatostatin limits intestinal ischemia-reperfusion injury in macaques via suppression of TLR4-NF-kappaB cytokine pathway. J Gastrointest Surg (2009) 13:983-93. doi:10.1007/s11605-009-0816-8
74. Shi Q, Cox LA, Glenn J, Tejero ME, Hondara V, Vandeberg JL, et al. Molecular pathways mediating differential responses to lipopolysaccharide between human and baboon arterial endothelial cells. Clin Exp Pharmacol Physiol (2010) 37:178-84. doi:10.1111/j.1440-1681.2009.05260.x
75. Iwami KI, Matsuguchi T, Masuda A, Kikuchi T, Musikacharoen T, Yoshikai Y. Cutting edge: naturally occurring soluble form of mouse toll-like receptor 4 inhibits lipopolysaccharide signaling. J Immunol (2000) 165:6682-6. doi:10.4049/jimmunol.165.12.6682
76. Lehnardt S, Lachance C, Patrizi S, Lefebvre S, Follett PL, Jensen FE, et al. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci (2002) 22:2478-86.
77. Frantz S, Kobzik L, Kim YD, Fukazawa R, Medzhitov R, Lee RT, et al. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest (1999) 104:271-80. doi:10.1172/JCI6709
78. Carrera-Silva EA, Cano RC, Guinazu N, Aoki MP, Pellegrini A, Gea S. TLR2, TLR4 and TLR9 are differentially modulated in liver lethally injured from BALB/c and C57BL/6 mice during Trypanosoma cruzi acute infection. Mol Immunol (2008) 45:3580-8. doi:10.1016/j.molimm.2008.05.004
79. Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M, et al. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol (2000) 164:3476-9. doi:10.4049/jimmunol.164.7.3476
80. Kawasaki K, Akashi S, Shimazu R, Yoshida T, Miyake K, Nishijima M. Mouse toll-like receptor 4.MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by taxol. J Biol Chem (2000) 275:2251-4. doi:10.1074/jbc.275.4.2251
81. Akashi S, Nagai Y, Ogata H, Oikawa M, Fukase K, Kusumoto S, et al. Human MD-2 confers on mouse toll-like receptor 4 species-specific lipopolysaccharide recognition. Int Immunol (2001) 13:1595-9. doi:10.1093/intimm/13.12.1595
82. Nahori MA, Fournie-Amazouz E, Que-Gewirth NS, Balloy V, Chignard M, Raetz CR, et al. Differential TLR recognition of leptospiral lipid A and lipopolysaccharide in murine and human cells. J Immunol (2005) 175:6022-31. doi:10.4049/jimmunol.175.9.6022
83. Hubert FX, Voisine C, Louvet C, Heslan JM, Ouabed A, Heslan M, et al. Differential pattern recognition receptor expression but stereotyped responsiveness in rat spleen dendritic cell subsets. J Immunol (2006) 177:1007-16. doi:10.4049/jimmunol.177.2.1007
84. Ren MY, Wu XY. Toll-like receptor 4 signalling pathway activation in a rat model of Acanthamoeba keratitis. Parasite Immunol (2011) 33:25-33. doi:10.1111/j.1365-3024.2010.01247.x
85. Hickey E, Shi H, Van Arsdell G, Askalan R. Lipopolysaccharide-induced preconditioning against ischemic injury is associated with changes in toll-like receptor 4 expression in the rat developing brain. Pediatr Res (2011) 70:10-4. doi:10.1038/pr.2011.235
86. Zhou ML, Wu W, Ding YS, Zhang FF, Hang CH, Wang HD, et al. Expression of toll-like receptor 4 in the basilar artery after experimental subarachnoid hemorrhage in rabbits: a preliminary study. Brain Res (2007) 1173:110-6. doi:10.1016/j.brainres.2007.07.059
87. Smith LS, Kajikawa O, Elson G, Wick M, Mongovin S, Kosco-Vilbois M, et al. Effect of toll-like receptor 4 blockade on pulmonary inflammation caused by mechanical ventilation and bacterial endotoxin. Exp Lung Res (2008) 34:225-43. doi:10.1080/01902140802022492
88. Raymond CR, Wilkie BN. Toll-like receptor, MHC II, B7 and cytokine expression by porcine monocytes and monocyte-derived dendritic cells in response to microbial pathogen-associated molecular patterns. Vet Immunol Immunopathol (2005) 107:235-47. doi:10.1016/j.vetimm.2005.05.008
89. Sorensen NS, Skovgaard K, Heegaard PM. Porcine blood mononuclear cell cytokine responses to PAMP molecules: comparison of mRNA and protein production. Vet Immunol Immunopathol (2011) 139:296-302. doi:10.1016/j.vetimm.2010.10.016
90. Uddin MJ, Nuro-Gyina PK, Islam MA, Tesfaye D, Tholen E, Looft C, et al. Expression dynamics of toll-like receptors mRNA and cytokines in porcine peripheral blood mononuclear cells stimulated by bacterial lipopolysaccharide. Vet Immunol Immunopathol (2012) 147:211-22. doi:10.1016/j.vetimm.2012.04.020
91. Gao Y, Flori L, Lecardonnel J, Esquerre D, Hu ZL, Teillaud A, et al. Transcriptome analysis of porcine PBMCs after in vitro stimulation by LPS or PMA/ionomycin using an expression array targeting the pig immune response. BMC Genomics (2010) 11:292. doi:10.1186/1471-2164-11-292
92. Burkey TE, Skjolaas KA, Dritz SS, Minton JE. Expression of toll-like receptors, interleukin 8, macrophage migration inhibitory factor, and osteopontin in tissues from pigs challenged with Salmonella enterica serovar typhimurium or serovar choleraesuis. Vet Immunol Immunopathol (2007) 115:309-19. doi:10.1016/j.vetimm.2006.11.012
93. Wassef A, Janardhan K, Pearce JW, Singh B. Toll-like receptor 4 in normal and inflamed lungs and other organs of pig, dog and cattle. Histol Histopathol (2004) 19:1201-8.
94. Moue M, Tohno M, Shimazu T, Kido T, Aso H, Saito T, et al. Toll-like receptor 4 and cytokine expression involved in functional immune response in an originally established porcine intestinal epitheliocyte cell line. Biochim Biophys Acta (2008) 1780:134-44. doi:10.1016/j.bbagen.2007.11.006
95. Miguel JC, Chen J, Van Alstine WG, Johnson RW. Expression of inflammatory cytokines and toll-like receptors in the brain and respiratory tract of pigs infected with porcine reproductive and respiratory syndrome virus. Vet Immunol Immunopathol (2010) 135:314-9. doi:10.1016/j.vetimm.2010.01.002
96. Burgener IA, Konig A, Allenspach K, Sauter SN, Boisclair J, Doherr MG, et al. Upregulation of toll-like receptors in chronic enteropathies in dogs. J Vet Intern Med (2008) 22:553-60. doi:10.1111/j.1939-1676.2008.0093.x
97. Swerdlow MP, Kennedy DR, Kennedy JS, Washabau RJ, Henthorn PS, Moore PF, et al. Expression and function of TLR2, TLR4, and Nod2 in primary canine colonic epithelial cells. Vet Immunol Immunopathol (2006) 114:313-9. doi:10.1016/j.vetimm.2006.09.003
98. British Pharmacopeia. (2012). Available from: http://www.pharmacopoeia.co.uk/ (Volume V, Supplementary Chapters SC I Basis of Pharmacopeial Requirements)
99. Brinkworth JF, Pechenkina EA, Silver J, Goyert SM. Innate immune responses to TLR2 and TLR4 agonists differ between baboons, chimpanzees and humans. J Med Primatol (2012) 41(6):388-93. doi:10.1111/jmp.12002
100. Haudek SB, Natmessnig BE, Furst W, Bahrami S, Schlag G, Redl H. Lipopolysaccharide dose response in baboons. Shock (2003) 20:431-6. doi:10.1097/01.shk.0000090843.66556.74
101. United States Pharmacopeia. (2010). Available from: http://www.pharmacopeia.cn/v29240/usp29nf24s0_c151.html (General Chapters: 151 PYROGEN TEST)
102. Fink MP, Morrissey PE, Stein KL, Clement RE, Fiallo V, Gardiner WM. Systemic and regional hemodynamic effects of cyclo-oxygenase and thromboxane synthetase inhibition in normal and hyperdynamic endotoxemic rabbits. Circ Shock (1988) 26:41-57.
103. Wyler F, Neutze JM, Rudolph AM. Effects of endotoxin on distribution of cardiac output in unanesthetized rabbits. Am J Physiol (1970) 219:246-51.
104. Lee K, van der ZH, Dziuban SW Jr, Luhmann K, Goldfarb RD. Left ventricular function during chronic endotoxemia in swine. Am J Physiol (1988) 254:H324-30.
105. Sakaue Y, Nezu Y, Komori S, Hara Y, Tagawa M, Ogawa R. Evaluation of hepatosplanchnic circulation and intestinal oxygenation in dogs with a condition that mimicked septic shock induced by continuous infusion of a low dose of lipopolysaccharide. Am J Vet Res (2004) 65:1347-54. doi:10.2460/ajvr.2004.65.1347
106. Marcuzzi A, Secchiero P, Crovella S, Zauli G. TRAIL administration down-modulated the acute systemic inflammatory response induced in a mouse model by muramyldipeptide or lipopolysaccharide. Cytokine (2012) 60:43-6. doi:10.1016/j.cyto.2012.06.001
107. Khan NA, Vierboom MP, Holten-Neelen C, Breedveld E, Zuiderwijk-Sick E, Khan A, et al. Mitigation of septic shock in mice and rhesus monkeys by human chorionic gonadotrophin-related oligopeptides. Clin Exp Immunol (2010) 160:466-78. doi:10.1111/j.1365-2249.2010.04112.x
108. Fish RE, Spitzer JA. Continuous infusion of endotoxin from an osmotic pump in the conscious, unrestrained rat: a unique model of chronic endotoxemia. Circ Shock (1984) 12:135-49.
109. Bahrami S, Redl H, Buurman WA, Schlag G. Influence of the xanthine derivate HWA 138 on endotoxin-related coagulation disturbances: effects in non-sensitized vs D-galactosamine sensitized rats. Thromb Haemost (1992) 68:418-23.
110. Brackett DJ, Schaefer CF, Tompkins P, Fagraeus L, Peters LJ, Wilson MF. Evaluation of cardiac output, total peripheral vascular resistance, and plasma concentrations of vasopressin in the conscious, unrestrained rat during endotoxemia. Circ Shock (1985) 17:273-84.
111. Nguyen M, Leuridan E, Zhang T, De Wit D, Willems F, Van Damme P, et al. Acquisition of adult-like TLR4 and TLR9 responses during the first year of life. PLoS One (2010) 5:e10407. doi:10.1371/journal.pone.0010407
112. Roach JC, Glusman G, Rowen L, Kaur A, Purcell MK, Smith KD, et al. The evolution of vertebrate toll-like receptors. Proc Natl Acad Sci U S A (2005) 102:9577-82. doi:10.1073/pnas.0502272102
113. Redl H, Bahrami S, Schlag G, Traber DL. Clinical detection of LPS and animal models of endotoxemia. Immunobiology (1993) 187:330-45. doi:10.1016/S0171-2985(11)80348-7
114. Mathiak G, Kabir K, Grass G, Keller H, Steinringer E, Minor T, et al. Lipopolysaccharides from different bacterial sources elicit disparate cytokine responses in whole blood assays. Int J Mol Med (2003) 11:41-4. doi:10.3892/ijmm.11.1.41